Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections

This cohort study examines the use of intravitreal injections of vascular endothelial growth factor inhibitor in Denmark from 2007 through 2022 and forecasts future demand for this therapy.

Detalles Bibliográficos
Autores principales: Thinggaard, Benjamin Sommer, Pedersen, Frederik, Grauslund, Jakob, Stokholm, Lonny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517372/
https://www.ncbi.nlm.nih.gov/pubmed/37738053
http://dx.doi.org/10.1001/jamanetworkopen.2023.35148
_version_ 1785109305812320256
author Thinggaard, Benjamin Sommer
Pedersen, Frederik
Grauslund, Jakob
Stokholm, Lonny
author_facet Thinggaard, Benjamin Sommer
Pedersen, Frederik
Grauslund, Jakob
Stokholm, Lonny
author_sort Thinggaard, Benjamin Sommer
collection PubMed
description This cohort study examines the use of intravitreal injections of vascular endothelial growth factor inhibitor in Denmark from 2007 through 2022 and forecasts future demand for this therapy.
format Online
Article
Text
id pubmed-10517372
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-105173722023-09-24 Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections Thinggaard, Benjamin Sommer Pedersen, Frederik Grauslund, Jakob Stokholm, Lonny JAMA Netw Open Research Letter This cohort study examines the use of intravitreal injections of vascular endothelial growth factor inhibitor in Denmark from 2007 through 2022 and forecasts future demand for this therapy. American Medical Association 2023-09-22 /pmc/articles/PMC10517372/ /pubmed/37738053 http://dx.doi.org/10.1001/jamanetworkopen.2023.35148 Text en Copyright 2023 Thinggaard BS et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Thinggaard, Benjamin Sommer
Pedersen, Frederik
Grauslund, Jakob
Stokholm, Lonny
Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
title Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
title_full Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
title_fullStr Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
title_full_unstemmed Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
title_short Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
title_sort intravitreal vascular endothelial growth factor inhibitor therapy in denmark and 5-year projections
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517372/
https://www.ncbi.nlm.nih.gov/pubmed/37738053
http://dx.doi.org/10.1001/jamanetworkopen.2023.35148
work_keys_str_mv AT thinggaardbenjaminsommer intravitrealvascularendothelialgrowthfactorinhibitortherapyindenmarkand5yearprojections
AT pedersenfrederik intravitrealvascularendothelialgrowthfactorinhibitortherapyindenmarkand5yearprojections
AT grauslundjakob intravitrealvascularendothelialgrowthfactorinhibitortherapyindenmarkand5yearprojections
AT stokholmlonny intravitrealvascularendothelialgrowthfactorinhibitortherapyindenmarkand5yearprojections

Ejemplares similares